Dose-exposure-response relationship of insulin glulisine (HMR1964) in subjects with type 1 diabetes mellitus assessed with the euglycemic clamp technique using the Biostator (TM)

Trial Profile

Dose-exposure-response relationship of insulin glulisine (HMR1964) in subjects with type 1 diabetes mellitus assessed with the euglycemic clamp technique using the Biostator (TM)

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2009

At a glance

  • Drugs Insulin; Insulin glulisine
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Sanofi
  • Most Recent Events

    No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top